243 related articles for article (PubMed ID: 28082020)
1. miR424-5p functions as an anti-oncogene in cervical cancer cell growth by targeting KDM5B via the Notch signaling pathway.
Zhou Y; An Q; Guo RX; Qiao YH; Li LX; Zhang XY; Zhao XL
Life Sci; 2017 Feb; 171():9-15. PubMed ID: 28082020
[TBL] [Abstract][Full Text] [Related]
2. Original Research: miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells.
Cui G; Liu D; Li W; Li Y; Liang Y; Shi W; Zhao S
Exp Biol Med (Maywood); 2017 Jan; 242(1):45-52. PubMed ID: 27480251
[TBL] [Abstract][Full Text] [Related]
3. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
4. miR-194 inhibits gastric cancer cell proliferation and tumorigenesis by targeting KDM5B.
Bao J; Zou JH; Li CY; Zheng GQ
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4487-4493. PubMed ID: 27874950
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA HOXA-AS2 Facilitates Prostate Cancer Progression by Inhibiting miR-885-5p to Upregulate KDM5B.
Yang Z; Zhang F; Cai K; Xu J
Kidney Blood Press Res; 2023; 48(1):45-55. PubMed ID: 36404720
[TBL] [Abstract][Full Text] [Related]
6. Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
Dai B; Hu Z; Huang H; Zhu G; Xiao Z; Wan W; Zhang P; Jia W; Zhang L
Biochem Biophys Res Commun; 2014 Nov; 454(1):221-7. PubMed ID: 25450384
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG20 promotes cell proliferation and invasion via miR-140-5p-ADAM10 axis in cervical cancer.
Guo H; Yang S; Li S; Yan M; Li L; Zhang H
Biomed Pharmacother; 2018 Jun; 102():749-757. PubMed ID: 29604594
[TBL] [Abstract][Full Text] [Related]
8. HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.
Peta E; Sinigaglia A; Masi G; Di Camillo B; Grassi A; Trevisan M; Messa L; Loregian A; Manfrin E; Brunelli M; Martignoni G; Palù G; Barzon L
Oncogene; 2018 Mar; 37(12):1654-1668. PubMed ID: 29335520
[TBL] [Abstract][Full Text] [Related]
9. microRNA-486-5p functions as a tumor suppressor in gastric carcinoma via directly targeting KDM5B.
Li YB; Fan XY; Ning L; Li SK; Yu ZP
J Biol Regul Homeost Agents; 2021 Jul; 35(Special Issue on Internal Medicine n.1):. PubMed ID: 34327974
[No Abstract] [Full Text] [Related]
10. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma.
Li L; Shou H; Wang Q; Liu S
Gene; 2019 Apr; 694():76-82. PubMed ID: 30658067
[TBL] [Abstract][Full Text] [Related]
11. Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3.
Li J; Chu ZP; Han H; Zhang Y; Tian F; Zhang JQ; Huang XH
Hum Cell; 2019 Apr; 32(2):160-171. PubMed ID: 30689165
[TBL] [Abstract][Full Text] [Related]
12. Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis.
Huang J; Jin S; Guo R; Wu W; Yang C; Qin Y; Chen Q; He X; Qu J; Yang Z
RNA; 2024 Mar; 30(4):435-447. PubMed ID: 38296629
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
Qin X; Wan Y; Wang S; Xue M
Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.
Hayami S; Yoshimatsu M; Veerakumarasivam A; Unoki M; Iwai Y; Tsunoda T; Field HI; Kelly JD; Neal DE; Yamaue H; Ponder BA; Nakamura Y; Hamamoto R
Mol Cancer; 2010 Mar; 9():59. PubMed ID: 20226085
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
16. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.
Wang D; Han S; Peng R; Jiao C; Wang X; Yang X; Yang R; Li X
J Exp Clin Cancer Res; 2016 Feb; 35():37. PubMed ID: 26911146
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1.
Chu Y; Ouyang Y; Wang F; Zheng A; Bai L; Han L; Chen Y; Wang H
J Cell Biochem; 2014 May; 115(5):847-53. PubMed ID: 24288179
[TBL] [Abstract][Full Text] [Related]
18. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
[TBL] [Abstract][Full Text] [Related]
19. MiR-520d-5p functions as a tumor-suppressor gene in cervical cancer through targeting PTK2.
Zhang L; Liu F; Fu Y; Chen X; Zhang D
Life Sci; 2020 Aug; 254():117558. PubMed ID: 32198053
[TBL] [Abstract][Full Text] [Related]
20. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
